Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
批准号:
10303952
负责人:
Daylon J James
金额:
$23.17万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-29 至 2023-06-30
关键词:
AcuteAddressAdolescentAdultAdverse effectsAffectAnimal ModelAttentionAutologous TransplantationCancer PatientChildChildhoodChronicChronic DiseaseClinicalCryopreservationDevelopmentDiagnosisDiseaseDisease remissionEmbryoEndocrineEnvironmentFDA approvedFemaleFertilityFormulationFoundationsFreezingGerm CellsGoalsGonadal structureGraft SurvivalHealthHumanInfertilityInflammatoryLive BirthLongevityMacacaMacaca mulattaMalignant NeoplasmsMessenger RNAMethodologyMethodsModalityMolecularOocytesOrgan DonorOutcomeOutputOvarianOvarian FollicleOvarian TissueOvarian tissue cryopreservationOvariectomyPathologyPatient RepresentativePatientsPhasePremature MenopausePrimordial FollicleProceduresProductionProductivityProtocols documentationQuality of lifeRecombinantsRecoveryRhesusSiteSliceStandardizationSurvival RateSystemTestingTherapeuticThinnessTissue SurvivalTissue TransplantationTissuesTransplantationVEGFA geneWorkXenograft procedurebasechemotherapyexperimental studyfertility preservationgirlshuman tissueimprovedmullerian-inhibiting hormonenovelovarian reserveovary transplantationpatient populationpersonalized diagnosticspost-transplantpre-clinicalprepubertypreservationreproductivesuccessyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
With increased diagnostic precision and expanded treatment options, the health and lifespan of children
born with chronic diseases has extended significantly into adulthood, drawing attention to preserving their
quality of life and reproductive options. Unfortunately, the pathology of many chronic conditions can have
negative consequences for the gonad, resulting in infertility and/or premature menopause.
Cryopreservation (and later auto-transplantation) of whole ovarian tissue could provide a means of “safe-
guarding” ovarian reserve from the gonadotoxic effects of disease pathology, and this approach has been
utilized in cancer patients to yield at least 100 live births since early attempts more than a decade ago.
Although this approach is effective, the viability and productivity of cryopreserved ovarian tissue is
drastically undermined by the inflammatory, ischemic environment within the graft during the acute phase
post-transplant.
This proposal leverages the potent bioactivity and straightforward delivery of modified mRNA
(modRNA) as a therapeutic approach to improving the viability and output of ovarian tissue autografts.
Using a xenograft platform developed by our group, we will investigate the potential for modRNA to: 1)
improve viability and output of ovarian tissue transplanted for the purpose of fertility preservation; 2)
maintain a robust pool of ovarian follicles in a quiescent primordial state that will serve as a long-term
reservoir for normalization of endocrine function and oocyte output; and 3) demonstrate the efficacy of this
approach in a highly relevant pre-clinical animal model, rhesus macaque. With these experiments we will
establish a foundation for robust, repeatable and FDA-approvable methods for ovarian tissue
cryopreservation/auto-transplantation in chronically diseased girls that wish to maintain their reproductive
options.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue.
-
批准号:10719540
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2023
-
负责人:Daylon J James
-
依托单位:
Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
-
批准号:10458028
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2021
-
负责人:Daylon J James
-
依托单位:
海外基金